Aveanna Healthcare Holdings (AVAH) Cost of Revenue (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has reported Cost of Revenue for 7 consecutive years, with $449.2 million the latest figure, recorded in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $449.2 million, up 29.02% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.6 billion (up 16.83% YoY), and the FY2026 annual result was $1.6 billion, up 16.83% from the prior year.
• Cost of Revenue was $449.2 million for Q1 2026 at Aveanna Healthcare Holdings, up from $419.1 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $449.2 million in Q1 2026 and troughed at $297.9 million in Q3 2022.
• Average Cost of Revenue over 5 years is $349.3 million, with a median of $344.8 million recorded in 2024.
• Year-over-year, Cost of Revenue dropped 17.7% in 2022 and gained 29.02% in 2026.
• Over 5 years, Cost of Revenue stood at $322.4 million in 2022, then grew by 2.49% to $330.4 million in 2023, then gained by 5.37% to $348.2 million in 2024, then increased by 20.38% to $419.1 million in 2025, then increased by 7.17% to $449.2 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $449.2 million in Q1 2026, $419.1 million in Q3 2025, and $378.8 million in Q2 2025.